MOUSE EMBRYONIC STEM-CELLS CARRYING ONE OR 2 DEFECTIVE MSH2 ALLELES RESPOND ABNORMALLY TO OXIDATIVE STRESS INFLICTED BY LOW-LEVEL RADIATION

Citation
Tl. Deweese et al., MOUSE EMBRYONIC STEM-CELLS CARRYING ONE OR 2 DEFECTIVE MSH2 ALLELES RESPOND ABNORMALLY TO OXIDATIVE STRESS INFLICTED BY LOW-LEVEL RADIATION, Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 11915-11920
Citations number
49
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
95
Issue
20
Year of publication
1998
Pages
11915 - 11920
Database
ISI
SICI code
0027-8424(1998)95:20<11915:MESCOO>2.0.ZU;2-T
Abstract
Chronic oxidative stress may play a critical role in the pathogenesis of many human cancers. Here, we report that mouse embryonic stem (ES) cells deficient in DNA mismatch repair responded abnormally when expos ed to low levels of ionizing radiation, a stress known to generate oxi dative DNA damage. ES cells derived from mice carrying either one or t wo disrupted Msh2 alleles displayed an increased survival following pr otracted exposures to low-level ionizing radiation as compared with wi ld-type ES cells. The increases in survival exhibited by ES cells defi cient in DNA mismatch repair appeared to have resulted from a failure to efficiently execute cell death (apoptosis) in response to radiation exposure. For each of the ES cell types, prolonged low-level radiatio n treatment generated oxidative genome damage that manifested as an ac cumulation of oxidized bases in genomic DNA. However, ES cells from Ms h2(+/-) and Msh2(-/-) mice accumulated more oxidized bases as a conseq uence of low-level radiation exposure than ES cells from Msh2(+/+) mic e. The propensity for normal cells with mismatch repair enzyme deficie ncies, including cells heterozygous for inactivating mismatch repair e nzyme gene mutations, to survive promutagenic genome insults accompany ing oxidative stresses may contribute to the increased cancer risk cha racteristic of the hereditary nonpolyposis colorectal cancer syndrome.